Pharma Industry News

information-analysis-insights

  • Home
  • Directories
  • Reports
  • Know Us
  • News
    • New Projects
    • New Launches
    • Formulations
    • Insights
    • New Drugs
    • BioTechnology
    • Ayurvedic Drugs

Jubilant

Jubilant Life Sciences to expand capacity and R&D

September 14, 2018 IbisResearch 0

Jubilant Life Sciences is expanding its production capacity at Roorkee in Uttaranchal. The company has earmarked Rs 5500 million for capital expenditure (capex) in the […]

Jubilant Life Sciences receives USFDA approval for Amantadine Hydrochloride

February 10, 2018 IbisResearch 0

Jubilant Life Sciences has received final USFDA approval for Amantadine Hydrochloride tablets, an anti-viral and anti-Parkinsons drug. The drug is a generic version of Symmetrel […]

Jubilant Life Sciences has received USFDA approval for Indocin

November 5, 2017 IbisResearch 0

Jubilant Life Sciences has received final USFDA approval for the generic version of its non-steroidal anti-inflammatory drug, Indocin. The approval for Indomethacin capsules is a […]

Jubilant Life Sciences receives USFDA approval for Bupropion Hydrochloride

July 7, 2017 IbisResearch 0

Jubilant Life Sciences through its subsidiary has received final USFDA approval for Bupropion Hydrochloride extended-release tablets, used for the treatment of major depressive disorder and […]

No Image

Jubilant Life Sciences receives USFDA approval for Darifenacin

November 1, 2016 IbisResearch 0

Jubilant Life Sciences has received the final USFDA approval for Darifenacin Extended-Release Tablets, used for the treatment of urinary incontinence. The company has received Abbreviated […]

Jubilant Life Sciences receives USFDA approval for Telmisartan

September 20, 2016 IbisResearch 0

Jubilant Life Sciences has received USFDA approval for Telmisartan Tablets, used for the treatment of hypertension, in the U.S. market. The final approval is for […]

Jubilant Life Sciences recieves approval for anti-depressant Paxil

January 3, 2016 IbisResearch 0

Jubilant Life Sciences Ltd has received final approval from USFDA for its generic version of anti-depressant Paxil tablets. The final approval for the abbreviated new […]

Jubliant Life Sciences receives ANDA final approval for Levofloxacin

June 30, 2015 IbisResearch 0

Jubliant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval for Levofloxacin tablets, 250mg and 500mg, the generic version of Levaquin Tablets. It […]

Segments

Ayurvedic Drugs
BioTechnology
Bulk Drugs
CRAMS
Formulations

Recent Posts

  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production
  • Perennial Medicare Pvt Ltd
  • Pasteur Laboratories Pvt Ltd

Search

About

Ibis Research-which maintains this site - aims to tracks core industrial sectors. It records Indian Pharmaceutical sector news, updates, technology trends, company profiles, updates address directories, tracks new project investments, posting updates on the latest development.

It provides timely information, analysis and insights.

This website tracks state government policies, employment opportunities in the sector, industry climate and economy forecast etc.,

New Projects
  • Maharashtra government plans new bulk drug park in Raigad

    November 21, 2020 0
  • Karnataka government plans new Bio Technology park near Bengaluru

    August 1, 2020 0
  • Desano Pharmaceuticals plans new manufacturing facility in Harohalli

    November 29, 2019 0
  • Union Government to develop a bulk drug park in Himachal Pradesh

    November 26, 2019 0
  • Suven Life Science plans expansion programme

    September 22, 2019 0
Latest News
  • Maharashtra government plans new bulk drug park in Raigad
  • Karnataka government plans new Bio Technology park near Bengaluru
  • Union Government incentives local API production
  • Perennial Medicare Pvt Ltd
  • Pasteur Laboratories Pvt Ltd

Copyright © 2021 | WordPress Theme by MH Themes